Literature DB >> 20606623

Regression of metastatic seminoma in a patient referred for carcinoma of unknown primary origin.

John E Musser1, Christopher G Przybycin, Paul Russo.   

Abstract

BACKGROUND: A 63-year-old man presented to an emergency department with abdominal and back pain. A 5 x 3 x 2 cm para-aortic mass was found adjacent to the left kidney, but the location of the primary tumor could not be identified. He was referred to a tertiary center with a diagnosis of retroperitoneal carcinoma of unknown primary origin. Atrophy of the left testicle was noted. Review of the biopsy material obtained at the first presentation showed histology characteristic of seminoma, and imaging revealed the presence of small intratesticular lesions. Repeat CT showed complete resolution of the metastatic para-aortic mass. The patient underwent left orchiectomy and adjuvant radiation therapy, and showed no signs of disease 6 months later. INVESTIGATIONS: CT of the chest, abdomen and pelvis, measurement of serum tumor markers, upper gastrointestinal endoscopy, colonoscopy, PET-CT and percutaneous needle biopsy of the para-aortic mass at the first presentation; physical examination, review of biopsy specimen with immunohistochemical staining for tumor markers, testicular ultrasonography and repeat CT of the chest, abdomen and pelvis at the second presentation. DIAGNOSIS: Metastatic seminoma with spontaneous regression of the metastatic lesion. MANAGEMENT: Radical orchiectomy and adjuvant radiation therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20606623     DOI: 10.1038/nrurol.2010.99

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  26 in total

Review 1.  Surgery for a post-chemotherapy residual mass in seminoma.

Authors:  H W Herr; J Sheinfeld; H S Puc; R Heelan; D F Bajorin; P Mencel; G J Bosl; R J Motzer
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

2.  Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.

Authors:  R T D Oliver; M D Mason; G M Mead; H von der Maase; G J S Rustin; J K Joffe; R de Wit; N Aass; J D Graham; R Coleman; S J Kirk; S P Stenning
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

3.  Spontaneous regression of metastases from testicular tumours. A report of six cases from one centre.

Authors:  C I Franklin
Journal:  Clin Radiol       Date:  1977-09       Impact factor: 2.350

4.  Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases.

Authors:  G Krag Jacobsen; H Barlebo; J Olsen; H P Schultz; H Starklint; H Søgaard; M Vaeth
Journal:  Acta Radiol Oncol       Date:  1984

5.  Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.

Authors:  J D Hainsworth; D H Johnson; F A Greco
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544

6.  Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: benefits of a 10-year follow-up study.

Authors:  Y C Bayens; P A Helle; W L Van Putten; S P Mali
Journal:  Radiother Oncol       Date:  1992-10       Impact factor: 6.280

7.  European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

Authors:  Susanne Krege; Jörg Beyer; Rainer Souchon; Peter Albers; Walter Albrecht; Ferran Algaba; Michael Bamberg; István Bodrogi; Carsten Bokemeyer; Eva Cavallin-Ståhl; Johannes Classen; Christoph Clemm; Gabriella Cohn-Cedermark; Stéphane Culine; Gedske Daugaard; Pieter H M De Mulder; Maria De Santis; Maike de Wit; Ronald de Wit; Hans Günter Derigs; Klaus-Peter Dieckmann; Annette Dieing; Jean-Pierre Droz; Martin Fenner; Karim Fizazi; Aude Flechon; Sophie D Fosså; Xavier Garcia del Muro; Thomas Gauler; Lajos Geczi; Arthur Gerl; Jose Ramon Germa-Lluch; Silke Gillessen; Jörg T Hartmann; Michael Hartmann; Axel Heidenreich; Wolfgang Hoeltl; Alan Horwich; Robert Huddart; Michael Jewett; Johnathan Joffe; William G Jones; László Kisbenedek; Olbjørn Klepp; Sabine Kliesch; Kai Uwe Koehrmann; Christian Kollmannsberger; Markus Kuczyk; Pilar Laguna; Oscar Leiva Galvis; Volker Loy; Malcolm D Mason; Graham M Mead; Rolf Mueller; Craig Nichols; Nicola Nicolai; Tim Oliver; Dalibor Ondrus; Gosse O N Oosterhof; Luis Paz-Ares; Giorgio Pizzocaro; Jörg Pont; Tobias Pottek; Tom Powles; Oliver Rick; Giovanni Rosti; Roberto Salvioni; Jutta Scheiderbauer; Hans-Ulrich Schmelz; Heinz Schmidberger; Hans-Joachim Schmoll; Mark Schrader; Felix Sedlmayer; Niels E Skakkebaek; Aslam Sohaib; Sergei Tjulandin; Padraig Warde; Stefan Weinknecht; Lothar Weissbach; Christian Wittekind; Eva Winter; Lori Wood; Hans von der Maase
Journal:  Eur Urol       Date:  2007-12-26       Impact factor: 20.096

Review 8.  Diagnostic and therapeutic management of cancer of an unknown primary.

Authors:  N Pavlidis; E Briasoulis; J Hainsworth; F A Greco
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

9.  Spontaneous regression of retroperitoneal metastases from a primary pure anaplastic seminoma: a case report.

Authors:  D L Sarid; I G Ron; I Avinoach; F Sperber; M J Inbar
Journal:  Am J Clin Oncol       Date:  2002-08       Impact factor: 2.339

10.  A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.

Authors:  A Horwich; R T Oliver; P M Wilkinson; G M Mead; S J Harland; M H Cullen; J T Roberts; S D Fossa; D P Dearnaley; E Lallemand; S P Stenning
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.